Accueil・Liste d'Actions・Collegium Pharmaceutical Inc

C
Collegium Pharmaceutical Inc

Ouvert

SecteurSoins de santé

28.12 0.68

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

26.93

Max

28.33

Chiffres clés
By Trading Economics
Revenu	-30M -15M
Ventes	6.4M 200M
P/E Moyenne du Secteur	21.417 57.002
BPA	1.57
Marge bénéficiaire	-7.53
Employés	423
EBITDA	-20M 71M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+82.06% upside

Dividendes
By Acuity
Prochains Résultats	5 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-272M 882M
Ouverture précédente	27.44
Clôture précédente	28.12

Sentiment de l'Actualité

By Acuity

43%

57%

150 / 340 Classement par Healthcare

Collegium Pharmaceutical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 août 2026, 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

12 août 2026, 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

11 août 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

10 août 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

7 août 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

6 août 2026, 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

4 août 2026, 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

3 août 2026, 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

31 juil. 2026, 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

30 juil. 2026, 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

29 juil. 2026, 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

28 juil. 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

27 juil. 2026, 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

24 juil. 2026, 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

22 juil. 2026, 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

21 juil. 2026, 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

20 juil. 2026, 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Comparaison

Variation de prix

Collegium Pharmaceutical Inc prévision

Objectif de Prix

By TipRanks

82.06% hausse

Prévisions sur 12 Mois

Moyen 51.25 USD 82.06%

Haut 60 USD

Bas 43 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

Achat

Maintien

Vente

Basé sur 4 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

150 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.